Letter to the Editor: CHEK2 I157T - Pluto Among Numerous Low-Risk Genetic Factors Requiring Discharge From a Range of Pathogenic Variants?

Maxim Ivanov^{1

2}, Margarita Sharova^{1

3}, Andrea Olsen¹, Alexandra Lebedeva¹, Ekaterina Ignatova^{1

4

5}, Gerald Mouse¹, Vladislav Mileyko¹

Affiliations

¹ 1Atlas Oncodiagnostics, LLC, Moscow, Russia.
² 2Moscow Institute of Physics of Technology, Dolgoprudny, Russia.
³ 3Research and Counselling Department, Research Centre for Medical Genetics, Moscow, Russia.
⁴ 4Department of Chemotherapy No. 2, Federal State Budgetary Institution N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia; and.
⁵ 5Department of Oncogenetics, Institute of Higher and Additional Professional Education, Research Centre for Medical Genetics, Moscow, Russia.

Comment

Maxim Ivanov et al. J Natl Compr Canc Netw. 2022 Feb.

. 2022 Feb;20(2):xxv.

doi: 10.6004/jnccn.2021.7103.

Maxim Ivanov^{1

2}, Margarita Sharova^{1

3}, Andrea Olsen¹, Alexandra Lebedeva¹, Ekaterina Ignatova^{1

4

5}, Gerald Mouse¹, Vladislav Mileyko¹

¹ 1Atlas Oncodiagnostics, LLC, Moscow, Russia.
² 2Moscow Institute of Physics of Technology, Dolgoprudny, Russia.
³ 3Research and Counselling Department, Research Centre for Medical Genetics, Moscow, Russia.
⁴ 4Department of Chemotherapy No. 2, Federal State Budgetary Institution N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Moscow, Russia; and.
⁵ 5Department of Oncogenetics, Institute of Higher and Additional Professional Education, Research Centre for Medical Genetics, Moscow, Russia.

No abstract available

Comment in

Reply to the Letter to the Editor From Ivanov et al.
Daly MB. Daly MB. J Natl Compr Canc Netw. 2022 Feb;20(2):xxvi. doi: 10.6004/jnccn.2022.0014. J Natl Compr Canc Netw. 2022. PMID: 35130498 No abstract available.

Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML; CGC; Karlan BY, Khan S, Klein C, Kohlmann W; CGC; Kurian AW, Laronga C, Litton JK, Mak JS; LCGC; Menendez CS, Merajver SD, Norquist BS, Offit K, Pederson HJ, Reiser G; CGC; Senter-Jamieson L; CGC; Shannon KM, Shatsky R, Visvanathan K, Weitzel JN, Wick MJ, Wisinski KB, Yurgelun MB, Darlow SD, Dwyer MA. Daly MB, et al. J Natl Compr Canc Netw. 2021 Jan 6;19(1):77-102. doi: 10.6004/jnccn.2021.0001. J Natl Compr Canc Netw. 2021. PMID: 33406487